Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial
Hoffmann-La Roche
Sumanta Kumar Pal; Robert Uzzo; Jose Antonio Karam; Viraj A Master; Frede Donskov; Cristina Suarez; Laurence Albiges; Brian Rini; Yoshihiko Tomita; Ariel Galapo Kann; Giuseppe Procopio; Francesco Massari; Matthew Zibelman; Igor Antonyan; Mahrukh Huseni; Debasmita Basu; Bo Ci; William Leung; Omara Khan; Sarita Dubey; Axel Bex